Workforce Nutrition Alliance Publishes Booklet Highlighting Ke... - 09 June 2022 04:27

PARIS and GENEVA, June 9, 2022 /PRNewswire-AsiaNet/ -- - 11 Organisations Provide Examples, Learnings and Recommendations on How to Improve Nutrition at Work The Consumer Goods Forum (CGF) and the Global Alliance for Improved Nutrition (GAIN) ( https://www.gainhealth.org/ ), as part of the Workforc...

  Medison Pharma Announces the Approvals by Health Canada and Th... - 09 June 2022 02:46

PETACH TIKVAH, Israel, June 8, 2022 /PRNewswire-AsiaNet/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, is pleased to announce the approval of KIMMTRAK(R) (tebentafusp) by Health Canada and Thera...

  LenioBio Reaches Industrial-Scale with its High-Yield Eukaryot... - 08 June 2022 10:00

DUSSELDORF, Germany, June 8, 2022/PRNewswire-AsiaNet/-- LenioBio GmbH today announced it had achieved a key milestone for the company with the successful linear scaling of its cell-free protein synthesis (CFPS) platform, ALiCE(R), to an industrial scale. Through a series of breakthrough developments...

  FDA Advisory Committee Recommends Emergency Use Authorization ... - 08 June 2022 09:16

GAITHERSBURG, Md., June 7, 2022 /ASIANET-PRNewswire/ -- --Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee --If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine ...

  First Patient Enrolled in SELUTION SLR IDE BTK Study - 08 June 2022 09:00

LEIPZIG, Germany, June 8, 2022 /PRNewswire-AsiaNet/ -- The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR(TM), MedAlliance's novel sirolimus-eluting balloon, just one week after receiving IDE approval. "I am excited to ...

  Menarini Group and Radius Health, Inc. present a subgroup anal... - 07 June 2022 02:44

FLORENCE, Italy and BOSTON, June 6, 2022 /PRNewswire-AsiaNet/-- Subgroup analysis of patients with no prior chemotherapy in EMERALD: A phase 3 trial evaluating elacestrant, an investigational oral selective estrogen receptor degrader (SERD), vs. investigator’s choice of endocrine monotherapy for ER+/HER2- adva...

  Medison Pharma Announces Multi-Regional Partnership Agreement ... - 06 June 2022 21:00

PETACH TIKVAH, Israel, June 6, 2022 /PRNewswire-AsiaNet/ -- Medison Pharma [http://www.medisonpharma.com/] ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced today an exclusive multi-regional agreement with argenx ...

  CStone and Pfizer announce NMPA approval of sugemalimab in pat... - 06 June 2022 15:55

SUZHOU, China, June 6, 2022 /PRNewswire-AsiaNet/ -- * The National Medical Products Administration approved sugemalimab for the treatment of patients with unresectable stage III non-small cell lung cancer whose disease has not progressed following concurrent or sequential platinum-based chemoradiot...

  Vazyme Releases 2021 Annual Report: Announces More Efforts in ... - 02 June 2022 15:34

NANJING, China, June 2, 2022 /PRNewswire-AsiaNet/-- Vazyme, China's leading biotechnology company, has recently released its 2021 annual report, revealing that the company has maintained a steady and solid growth throughout the past year. The report shows that it has achieved $289 million in operat...

  Cambrex Acquires Leading EU Stability Storage Company Q1 Scien... - 01 June 2022 21:00

EAST RUTHERFORD, NJ, June 1, 2022, /PRNewswire-AsiaNet/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced the acquisition of Q1 Scientific – a leading pro...